News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,032 Results
Type
Article (8015)
Company Profile (139)
Press Release (474782)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166740)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52873)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238194)
Policy (17899)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (479)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33155)
ALS (102)
Alzheimer's disease (965)
Antibody-drug conjugate (ADC) (253)
Approvals (10329)
Artificial intelligence (307)
ASCO (159)
Autoimmune disease (194)
Automation (27)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (103)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (498)
Cancer (3544)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (166)
Celiac Disease (1)
Cell therapy (463)
Cervical cancer (34)
Clinical research (47714)
Collaboration (1196)
Compensation (1386)
Complete response letters (33)
COVID-19 (749)
CRISPR (62)
C-suite (700)
Cystic fibrosis (84)
Data (5481)
Denatured (4)
Depression (101)
Dermatology (59)
Diabetes (332)
Diagnostics (4141)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (144)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (157)
Earnings (72995)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87420)
Executive appointments (677)
FDA (12267)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (16)
Frontotemporal dementia (23)
Funding (886)
Gene editing (123)
Generative AI (9)
Gene therapy (307)
GLP-1 (284)
Government (938)
Grass and pollen (2)
Guidances (278)
Healthcare (9307)
Hematology (94)
HIV (49)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (95)
Immuno-oncology (54)
Indications (149)
Infectious disease (934)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (246)
Interviews (41)
IPO (12377)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (14)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (487)
Lymphoma (240)
Machine learning (27)
Management (3)
Manufacturing (506)
Marketing (6)
MASH (115)
Medical device (8628)
Medtech (8745)
Mergers & acquisitions (14346)
Metabolic disorders (685)
mRNA (50)
Multiple sclerosis (100)
NASH (4)
Neurodegenerative disease (209)
Neuropsychiatric disorders (38)
Neuroscience (1775)
NextGen: Class of 2026 (3150)
Non-profit (840)
Obesity (219)
Opinion (10)
Ovarian cancer (155)
Pain (167)
Pancreatic cancer (190)
Parkinson's disease (195)
Partnered (11)
Patents (455)
Patient recruitment (473)
Peanut (31)
People (41108)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15425)
Phase 2 (21305)
Phase 3 (14346)
Pipeline (6600)
Policy (18)
Postmarket research (1570)
Preclinical (6524)
Press Release (34)
Prostate cancer (185)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (552)
Real estate (3019)
Recruiting (6)
Regulatory (14656)
Reports (16)
Research institute (579)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (97)
Series A (147)
Series B (116)
Service/supplier (4)
Sickle cell disease (61)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (47)
Vaccines (310)
Venture capital (17)
Weight loss (69)
Women's health (73)
Date
Today (46)
Last 7 days (261)
Last 30 days (1070)
Last 365 days (19110)
2026 (10558)
2025 (19252)
2024 (22987)
2023 (26542)
2022 (34589)
2021 (37167)
2020 (33474)
2019 (23276)
2018 (17471)
2017 (18765)
2016 (17920)
2015 (24263)
2014 (21679)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (68)
Alaska (2)
Arizona (290)
Arkansas (11)
Asia (17830)
Australia (2088)
California (11464)
Canada (3037)
China (499)
Colorado (462)
Connecticut (388)
Delaware (201)
Europe (24558)
Florida (1708)
Georgia (363)
Hawaii (2)
Idaho (46)
Illinois (674)
India (40)
Indiana (308)
Iowa (13)
Japan (383)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1146)
Massachusetts (7559)
Michigan (299)
Minnesota (534)
Mississippi (4)
Missouri (76)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2526)
New Mexico (11)
New York (2724)
North Carolina (1222)
North Dakota (4)
Northern California (5699)
Ohio (264)
Oklahoma (14)
Oregon (14)
Pennsylvania (2185)
Puerto Rico (20)
Rhode Island (29)
South America (405)
South Carolina (75)
South Dakota (1)
Southern California (4757)
Tennessee (113)
Texas (1847)
United States (37315)
Utah (342)
Vermont (1)
Virginia (144)
Washington D.C. (38)
Washington State (890)
West Virginia (1)
Wisconsin (71)
483,032 Results for "terarecon inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
ConcertAI’s TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
ConcertAI’s TeraRecon, the advanced visualization and AI Clinical SaaS category leader, today announced a partnership to offer medical imaging AI specialist Avicenna.AI’s CINA-iPE solution detecting the presence of incidental pulmonary embolisms as part of TeraRecon’s Eureka Clinical AI solution.
March 13, 2023
·
3 min read
Genetown
ConcertAI’s TeraRecon Expands AI Model and Clinical Collaboration Capabilities of Eureka Clinical AI
ConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS category leader, announced the launch of its enhanced, next-generation Eureka Clinical AI platform.
May 8, 2023
·
4 min read
Genetown
ConcertAI’s TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders
ConcertAI’s TeraRecon has announced the release of its AI-driven clinical suite, Neuro Suite.
April 28, 2023
·
3 min read
Genetown
ConcertAI’s TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23
ConcertAI’s TeraRecon has announced its Eureka Clinical AI platform is now available to European healthcare providers.
February 27, 2023
·
5 min read
Genetown
ConcertAI’s TeraRecon Brings Neuro-oncology Imaging into the Eureka Clinical AI Platform with Imaging Biometrics Partnership
The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now provides clinicians with key quantitative insights and standardized metrics to make MR imaging analysis simple and fast with the addition of IB Clinic from Imaging Biometrics.
November 16, 2022
·
3 min read
Genetown
ConcertAI’s TeraRecon Expands AI, Partner, and Advanced Imaging Solutions at #RSNA22, Helping Clinicians Improve Efficiency and Care with Next Generation Eureka Clinical AI Platform
ConcertAI’s TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for medical imaging, recently unveiled first-in-category capabilities in advanced visualization, AI, and an AI solutions partner ecosystem to better meet clinician requirements in complex clinical workflows providing key augmentations enabling better outcomes for their patients.
November 28, 2022
·
4 min read
Bio NC
TeraRecon Expands Change Healthcare Distribution Agreement Adding AI Subscription
TeraRecon, the leading provider of AI-driven advanced visualization solutions, announced the expansion of their distribution offering to Change Healthcare customers for their AI-powered Intuition Subscription.
November 30, 2020
·
2 min read
Bio NC
TeraRecon Launches NVIDIA-Powered Clinical Training Cloud for Global Education
TeraRecon, the leading provider of AI-driven advanced visualization solutions, announced the debut of their Clinical Training Cloud for affordable imaging-based education initiatives across the US and Europe.
November 30, 2020
·
2 min read
Bio NC
TeraRecon Launches Intuition Subscription with Included Eureka AI Platform
TeraRecon Inc., the leading provider of advanced visualization and artificial intelligence solutions, recently launched the Intuition Titanium subscription, a new offering that includes a robust set of enterprise AI capabilities with the inclusion of future AI enhancements.
August 27, 2020
·
3 min read
Business
TeraRecon Adds Top Industry Leaders to Accelerate Next Phase of Growth
TeraRecon, the market leader in Advanced Visualization and Artificial Intelligence solutions for medical imaging, welcomes two new members to its executive team.
May 26, 2020
·
3 min read
1 of 48,304
Next